Aspire Biopharma Holdings, Inc. (ASBP)
9.00
+0.39
(+4.53%)
USD |
NASDAQ |
Sep 10, 14:41
Aspire Biopharma Holdings Total Liabilities (Quarterly) : 1.783M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.783M |
| March 31, 2026 | 3.249M |
| December 31, 2025 | 7.688M |
| September 30, 2025 | 13.87M |
| June 30, 2025 | 10.61M |
| March 31, 2025 | 8.918M |
| December 31, 2024 | 1.688M |
| September 30, 2024 | 6.573M |
| June 30, 2024 | 6.240M |
| March 31, 2024 | 2.633M |
| Date | Value |
|---|---|
| December 31, 2023 | 0.4033M |
| September 30, 2023 | 0.3163M |
| June 30, 2023 | 0.2844M |
| March 31, 2023 | 11.17M |
| December 31, 2022 | 11.12M |
| September 30, 2022 | 11.00M |
| June 30, 2022 | 10.96M |
| March 31, 2022 | 10.86M |
| December 31, 2021 | 0.2937M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Resonate Blends, Inc. | 8.188M |
| Breakthrough Chemistry, Inc. | 0.4631M |
| Kaya Holdings, Inc. | 2.920M |
| Cardiac Biotech Solutions, Inc. | 2.726M |
| Endexx Corp. | 35.33M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 13.54M |
| Shareholders Equity (Quarterly) | 11.76M |
| Current Ratio | 7.986 |
| Net Debt Paydown Yield | 19.56% |